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There is growing literature indicating the importance of pa-
tient representation of illness in their behavioral responses to 
health threats1. Cognitive perception of the illness is studied on 
the basis of cognitive-behavioral approaches or other similar 
theories such as social cognition models or personal construct 
theory1. Cognitive activities that include thoughts, images and 
behaviors concerning an evaluation of the environment form 
a broad network of information that helps researchers under-
stand how patients cope with the disease. Therefore, the envi-
ronmental influences of a person’s thoughts and feelings have 
an important contribution to behavioral health2,3.
Researchers in this field have made progress in the re-
search of psychological health in epilepsy by examining the 
role of cognition and coping style4,5. This approach is increas-
ing because patient perceptions explain greater differences in 
adaptation than biomedical variables4,6.
Epilepsy is a common neurological condition that affects 
the psychological adjustment and the quality, and it may 
therefore reveal a high incidence of fears, misunderstandings 
and stigma in these patients7,8. A chronic disease such as epi-
lepsy can be an important stress factor, and the inability to 
deal with the condition can bring psychological difficulties 
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AbStRACt
The objective of this study was to obtain reliability and validity evidence for the questionnaire of illness representation, the impact of epilepsy, 
and stigma (QIRIS) for use with adolescents and adults in Brazil. QIRIS consists of 14 questions grouped in three domains (attribution of 
meaning, impact of disease, and stigma) and was applied to 57 adults with epilepsy. QIRIS internal consistency was satisfactory (Cronbach’s 
α = 0. 866). Significant and strong correlation was found between issues belonging to the same domain, as expected. Three domains have 
highly significant and positive correlations with the instrument’s total score, indicating evidence of content validity. We conclude that QIRIS 
has psychometric properties and can facilitate a systematic evaluation of the patient’s representation according to a biopsychosocial 
approach that may contribute to clinical practice based on scientific evidence. 
Keywords: quality of life; stigma social; epilepsy; cognitive science; surveys and questionnaires.
ReSumo
Este estudo buscou evidências de confiabilidade e validade para o questionário de representação da doença, impacto da epilepsia e 
estigma (QIRIS), para uso em adolescentes e adultos no Brasil. O QIRIS consiste de 14 questões agrupadas em 3 domínios (atribuição de 
significados, impacto da doença e estigma) e foi aplicado em 57 adultos com epilepsia. A consistência interna do QIRIS foi satisfatória 
(α de Cronbach = 0,866). Foi encontrada forte e significante correlação entre as questões com o mesmo domínio.Os três domínios têm 
correlações altamente significativas e positivas com a pontuação total do instrumento, indicando evidências de validade de conteúdo. 
Concluímos que o QIRIS tem propriedades psicométricas que facilitam uma avaliação sistemática de representação do paciente de acordo 
com uma abordagem biopsicossocial, além de contribuir para uma prática clínica baseada em evidências científicas. 
Palavras-chave: qualidade de vida; estigma social; epilepsia; ciência cognitiva; inquéritos e questionários.
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and emotional distress9. Since one is diagnosed with epi-
lepsy, having the disease activates a behavior modifying sys-
tem of beliefs at the personal and social level. Furthermore, 
it involves expectations and perceptions that are individual 
intrapsychic categories related to each individual life story, 
which affects people in different manners7. 
An individual’s beliefs about his/her symptoms, diagnosis, 
label, causality, perception of duration, consequences of the 
disease, and perception of control integrate his or her con-
cept of “self ”10,11 with implications for feelings, behavior, and 
adjustment. Not only for the individual with epilepsy, but also 
for the entire family, especially because of the stigma related 
to this illness. The relationship between subjective variables, 
disease and socio-environmental demand is complex.
The illness representation theory supports the fact that 
all patients construct cognitive models of their illness, and 
also the fact that there is a dynamic relationship between its 
elements, where a patient’s cognitive perception changes in 
line with illness experience and consequences1,7.
The first approaches related to illness beliefs were ob-
tained from structured interviews with qualitative analysis 
without psychometric validation10 and other studies using a 
closed questionnaire with quantitative measures12,13. Kemp 
and Morley1 were the first to develop an interview that com-
bines open questions and a structured questionnaire.
Based on Kemp’s model, we developed a new psychologi-
cal protocol in order to assess cognitive representations in 
adults and adolescents with epilepsy.
Therefore, this paper aimed to find reliability and valid-
ity evidence for the questionnaire of illness representation, 
the impact of epilepsy, and stigma (QIRIS) and its use in Brazil.
metHoD 
Development of measure
Initially, the literature about related meanings, quality 
of life and stigma was reviewed.Some general points have 
emerged from this literature, such as: 1- All patients form 
representations early in the course of illness, and this repre-
sentation affects individual perception of their quality of life 
and, especially, individual perception of discrimination and 
rejection; 2- For an assessment of these beliefs, it is impor-
tant to make use of the psychological interview, to enable a 
qualitative analysis of subjective variables. In this study, the 
approach was to combine open-ended questions with rating 
scales, administrated in an interview format.
Aiming to evaluate how the impact of epilepsy is per-
ceived in our environment, an open exploratory 16-question 
questionnaire was developed. It sought to contemplate the 
main domains of epilepsy representation and our clinical 
experience in epilepsy. Questionnaire respondents included 
20 patients and 20 lay people from the local community14.
Briefly, the overall result showed that there is poor knowl-
edge of epilepsy among interviewees, although most of them 
have received information from their doctors. Concerning the 
social aspects, most of them referred to difficulties in work 
and school environments, also in establishing relationships. 
The main epilepsy related feelings reported by the subjects 
included sadness, dependence, inferiority, insecurity, fear and 
pity14. The open questionnaire was important to raise initial 
reactions about the concepts of epilepsy as well as the emo-
tional and social adjustment.
Based on the results of this first questionnaire, a panel of 
three independent specialists evaluated the questions; after-
wards, the most appropriate items were chosen15. The ques-
tionnaire used for the community had 16 closed questions 
about the medical (4 questions), social (10 questions) and 
personal (2 questions) areas. The patients questionnaire had 
four additional questions in the social and three in the per-
sonal area to be answered in the form of multiple-choice.The 
instrument was answered by 12 patients and 32 relatives from 
the Epilepsy Outpatients Clinic at the University Hospital of 
Campinas. Considering that patient beliefs are frequently in-
fluenced and reinforced by family members3, family beliefs 
should be investigated in parallel to the patients’16 in a broad-
er process of data collection.
The results are grouped in three main domains: medi-
cal, social and personal. Medical: patients and relatives did 
not know exactly what epilepsy is or how it is caused; none-
theless, they know how to treat it. Social: the most impor-
tant areas where people with epilepsy are discriminated 
are work and social relationships. Patients also complained 
about their lack of freedom and limits on recreation activi-
ties. Personal: subjects apparently have the same feelings and 
thoughts about epilepsy and seizures15.
Therefore, at the present stage, in order to validate 
the instrument to assess the perception of stigma in 
the community, we selected the most common answers 
(50% cut off ) in order to create the items for a version of 
stigma scale of epilepsy (SSE) containing five questions, 
with twenty-four items17. According to the results, the 
points focused on the five-question scale were sufficient 
to achieve this objective18.
Our intention now is different, as we seek to understand 
the psychological (cognitive and emotional) aspects related 
to the disease, as important contingencies in adaptive reac-
tions, from the perspective of the individual who has epilepsy.
The new questionnaire included answers identified 
in the social context (patients, relatives and community 
members) related to disease perception and impact, and as 
a psychological interview was drawn from questionnaires 
aimed at assessing cognitive representations. In this sense, 
it is important to note that the work of Weinman et al.13 and 
the research model developed by Kemp and Morley1 served 
as the basis for the final model that was selected as the ba-
sis for the scale proposed.
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The illness perception questionnaire (IPQ)13 comprises 
5 brief scales assessing the core components of an illness 
representation and appears to be psychometrically sound.
The five scales assess identity: 1) the symptoms the patient 
associates with the illness, cause; 2) personal ideas about 
etiology, time-line; 3) the perceived duration of the illness, 
consequences; 4) expected effects, and outcome and cure 
control; 5) how one controls or recovers from the illness. 
Each scale presents items whose content must be accepted 
or not by the patient.
Kemp and Morley1 aimed to assess six representation 
components of illness (identity, beliefs about symptoms 
and cause, consequences, beliefs about temporal course, 
control beliefs, self-illness relationship). The importance of 
the last one is based on the fact that the authors1 introduce 
open questions and include the item” consequences”, which 
investigates perceived stigma and enacted stigma1.
It is important to say that this new instrument that we 
are investigating maintains, in the same way proposed by 
other models1, open questions about stigma perception, 
but it also includes constructs linked to quality of life. The 
ease and speed of the application and correction process, 
which is indeed easier than others, are shown in a differen-
tial work in a hospital.
This version of the questionnaire (Appendix) for illness 
representation, the impact of epilepsy, and stigma (QIRIS) 
was composed of 14 questions grouped in three domains—
attribution of meaning, impact of the disease, and stigma—
and was tested with the aim of investigating its psychometric 
properties. The results of validity and reliability of the ques-
tionnaire for illness representation, the impact of epilepsy, 
and stigma (QIRIS) will be presented. 
Subjects
57 patients were involved in this study (71.93% female 
and 28.07% male) who were assisted at the epilepsy clinic 
located in a University Hospital. Participant ages ranged 
between 21 and 62 years (21% below 30 years, 26.32% aged 
30-39years; 35.1% 40-49 years, and 17.54%, above 50 years), 
31.43% were single, separated or divorced, 61.86% were 
married; 7.7% were widowed; 56.14% were unemployed and 
43.86% had a job; 68.42% have ≤ 8 years of education; and 
31.57% have ≥ 9 years of education. 
The clinical data  indicated that 31.55% had focal sei-
zures,54.39% showed focal plus generalized seizures, and 
14% had generalized seizures. Other data collected refer to 
the age at onset of seizures (M = 19.33, SD = 12.3), disease du-
ration (M = 17.22, SD = 12.1), and medication (monotherapy: 
85.7%, polytherapy: 14.3%). 
For this study, the inclusion criteria were: age between 18 
and 65, ability to answer the questions, and presence of ac-
tive epilepsy within the past 2 years. Patients were excluded 
if they had brain surgery, used concomitant medication with 
central nervous system effects, or had another progressive 
neurological or psychiatric illness. 
UNICAMP’s Committee of Ethics in Medicine ap-
proved this study. Written informed consent was obtained 
from the patients.
Instruments
1) Clinical and demographic identification questionnaire 
containing information on age, education, marital status, 
occupation, age of onset and duration of illness, seizure fre-
quency, type of seizure and medication used.
2) The questionnaire for illness representation, the 
impact of epilepsy, and stigma (QIRIS) is composed 
of 3 parts: I) Attribution of meaning [three open ques-
tions: a) Q1 – Label; b) Q2 – Causal Attributions; and 
c) Q5 – Projecting Consequences; and four Likert ques-
tions: a)  Q3 – Perceptions of Feelings; b) Q4 – Perception 
of Controllability ; c) Q6 - Coping; and d) Q7 – Perception 
of Social Consequences]; II) Impact of Disease [a sin-
gle open question: Q8 – Experience of difficulties; and 
two Likert questions: a) Q9 – Perceptions of difficulties; 
b) Q10 – Quality of Life], and III) Stigma [one open ques-
tion: Q11 – Experience of Stigma; and three Likert ques-
tions: a) Q12 – Perceived Discrimination; b) Q13 – Stigma; 
and c) Q14 – Perceived Stigma]. 
In the Likert questions, subjects can choose 1 of 4 alter-
natives, indicating how much they agree with the content. 
Some items are inverted in the correction process (Q4, Q6.1, 
Q6.2, Q7.2, Q7.3, Q7.4, and Q10). The sum of the total in each 
area is achieved by adding the scores of all items. The total 
scale is calculated by adding the scores of the three areas. 
The higher the total score, the more negative beliefs and the 
greater the impact on patient health.
Procedures
Instruments were applied in the Applied Psychology 
Clinic of the Neurology University Hospital, UNICAMP, 
Campinas/SP, Brazil. Patients completed the identification 
protocol and the questionnaire under the same conditions. 
The instruments were administered as an interview in adults 
with epilepsy.
ReSuLtS
Statistical analyses were performed using version 16.0 
of the Statistical Package for Social Sciences (SPSS) for 
Windows.Reliability was assessed by tests of internal con-
sistency for each domain using Cronbach’s alpha coeffi-
cient. The results are presented in Table 1. In the second 
analysis, the Spearman correlation was calculated between 
items (inter-score correlation) (Table 2). At the end, the cor-
relation between domains assessed by the Questionnaire 
was calculated (Table 3). 
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To carry out the statistical analysis, some QIRIS scores 
have to be reversed. These items are: Q4, Q6.1, Q6.2, Q7.2, Q7.3, 
Q7.4, Q10. It is also important to note that Q4 (Perception of 
Controllability), Q10 (Quality of Life), and Q13 (Stigma) do-
mains comprise only one item each, so Cronbach’s coeffi-
cient is not calculated for these cases.
The analysis of internal consistency generally showed 
that all items presented high values. Similarly, the total score 
also showed an adequate value (0.866). Considering each do-
main separately, we can see that Domain 1 – Attribution of 
meaning presented a .763 internal consistency. The results of 
the items that composed this domain showed good values 
for Q3 (.771), moderate value for Q7 (.559) and lower consis-
tency for Q6 (.215). In Domain 2 – Disease impact, consisten-
cy was .794 (Q9 presented a .775 value). Domain 3 – Stigma 
had .842 internal consistency and its Q9 and Q14 areas had 
.773 and .733, respectively. 
We can thus verify that the questionnaire had good in-
ternal consistency. The exception occurs in the Q7 – Social 
Consequences domain, which is lower than other domains, 
and in the Q6 – Coping domain, which presented an inad-
equate value. This is why future studies should consider re-
moving Q6.4 (item with the least consistency). For the time 
being, in face of the small sample size, we can consider that 
the questionnaire presented good psychometric standards 
related to reliability.
In order to understand the internal stability of the instru-
ment, we investigated the correlations between the scores 
of items of the questionnaire19. This analysis was based on 
Spearman’s correlation coefficient and is shown in Table 2.
According to the data, positive and significant corre-
lations were found between Q6 and Q7 (r = 0.53, p ≤ 0.001), 
Q9 and Q10 (r = 0.57, p ≤ 0.001), Q12 and Q13 (r = 0.43, p ≤ 
0.01), and Q12 and Q14 (r = 0.72, p ≤ 0.0001). The correlations 
between Q3 and Q4 was negative (-0.78, p ≤ 0.0001).
Remarkably, in Domain 1 – Attribution of meaning, 
the correlation between Perception of Feelings (Q3) and 
Perception of Controllability (Q4) was significant, but neg-
ative. Positive and significant correlations between the 
questions that evaluate Coping (Q6) and Perception of 
social consequences (Q7) were also observed. In Domain 
2 – Impact of Disease, the correlation between Perception 
of difficulties (Q9) and Quality of Life (Q10) was signifi-
cant and positive; in Domain 3 – Stigma, the correla-
tion between Perceived Discrimination (Q12) and Stigma 
(Q13) as well as the correlation between Perceived 
Discrimination (Q12) and Perceived Stigma (Q14) were 
positive and significant. The only relationship that was 
not significant occurred between Q13 (Stigma) and Q14 
(Perceived Stigma), belonging to the Stigma Domain. 
Considering that we hypothesized significant and 
strong correlations between issues belonging to the 
same domain, it was possible to note that most results 
met the expectations. 
Table 3 shows an analysis of correlations between the 
domains of the instrument. Therefore, it is possible to ob-
serve that the three domains have highly significant posi-
tive correlations with the total score of the instrument, 
Part 1 (r = 0.52; p ≤ 0.001), Part 2 (r = 0.75; p ≤ 0.0001), and 
Part 3 (r = 0.66; p ≤ 0.0001). It is also worth pointing out that 
Part 1 and Part 3 had a positive and significant correlation 
with each other (r = 0:35; p ≤ 0.01).
Table 1. Internal consistency of QIRIS questionnaire.
Part / Domains Cronbach’s alpha coefficient
Part 1 – Attribution of Meaning .763
Q3 – Perception of Feelings .771
Q6 – Coping .215
Q7 – Social Consequences .559
Part 2 – Disease Impact .794
Q9 – Perception of Difficulties .755
Part 3 – Stigma .842
Q12 – Perceived Discrimination .773
Q14 – Perceived Stigma .733
Total .866
Table 2. Spearman correlations between items of QIRIS questionnaire.
Item Q3 Q4 Q6 Q7 Q9 Q10 Q12 Q13
 Q4 -0.78*** - - - - -   -
Q6 0.12 -0.18 - - - - - -
Q7 0.35 -0.32 0.53** - - - - -
Q9 0.06 0.18 0,24 0.21 - - - -
Q10 -0.03 0.13 -0.04 0.04 0.57** - - -
Q12 0.09 0.05 0.05 0.22 0.26 0.03 - -
Q13 0.15 0.01 -0.09 -0.10 0.01 -0.02 0.43* -
Q14 0.05 0.02 0.21 0.30 0.29 0.06 0.72*** -0.14
*p ≤ 0.01; **p ≤ 0.001; ***p ≤ 0.0001 
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The purpose of the open questions in this questionnaire 
is to provide a qualitative analysis, though this type of analy-
sis was not the subject of this paper. However, we found it in-
teresting to show that the open questions are related to one 
another, and thus established the criteria considering the 
question that starts each domain. These questions were cat-
egorized and the analysis involved the Mann-Whitney test 
and showed interesting and expected results. 
The results showed that the Q1-Label related with 
Diagnosis (Yes / No) was significant with Q9 –Perceptions 
of Difficulties (p = 0.004). Furthermore, Q1 – Meaning of ep-
ilepsy (Negative / Positive) showed significant differences 
for Coping – Q6 (p = 0.043), Perceptions of Difficulties – Q9 
(p = 0.039), and had significant correlation with the total 
score of Part 2 – Quality of life (p = 0.039) and Total score 
of QIRIS (p = 0.045). Open question Q8 – Experience 
of Difficulties was significant with Q9 – Perceptions of 
Difficulties (p = 0.004) and total score of Part 2 – Quality of 
life (p = 0.005).Q11 – Stigma experience (Negative / Positive) 
was not associated with any question of the QIRIS.
The validity based on Mann-Whitney test was per-
formed to examine the relationship between the scores 
of the QIRIS and socio-demographic variables.No 
Employed was significant with Part1 and Part3 (p = 0.028 
and p = 0.035, respectively) and also with questions Q3 
(p = 0.023), Q4 (p = 0.0054), and Q13 (p = 0.021). The re-
lationship between Marital status and Perceived stigma 
(Q14) was significant (p = 0.048). Education was positive-
ly related with Part1 (p = 0.049). Based on Kruskall-Wallis 
test, we compared the clinical variables that showed dif-
ferences between focal plus generalized seizures and 
generalized seizures (p = 0.047).
DISCuSSIoN
This study aimed to describe a new questionnaire to as-
sess epilepsy representations, impact of disease and stigma. 
The purpose comprised the psychological (cognitive and 
emotional) aspects related to the disease as important con-
tingencies in adaptive reactions.
During the development of the questionnaire process and 
the search for validation evidence, an important step to men-
tion is the need for methodological accuracy in relation to 
the theoretical background, objectives, and conditions that 
will emerge and the level of analysis (use in clinical practice 
or research). Based on that, all phases of the study related in 
this paper were important.
The new questionnaire, as a psychological interview, was 
drawn from questionnaires aimed to assess cognitive repre-
sentations, including the answers identified in the social con-
text (patients, relatives, and community people). This is a ma-
jor contribution and an advantage.
In this sense, the questionnaire showed good psycho-
metric standards. The QIRIS items proved to be interdepen-
dent and homogeneous in terms of the concepts they mea-
sure, as indicated by the Cronbach coefficients and scale 
inter-correlation. Reliability and accuracy were satisfactory.
Although questions Q6 and Q7 were slightly below 0.70 in 
the Cronbach analysis, these items appear closely related in 
scale inter-correlation.
We hypothesized strong correlations among questions 
with the same content and that has been showed in sev-
eral studies9,20,21. People who perceive poor control of the 
disease (Q4) are found to usually experience more negative 
feelings (Q3), and this was a highly significant correlation. 
An important psychological aspect to be highlighted is the 
belief that they have little personal control, and such a gen-
eral outlook is associated with a more passive stance and 
depressive thinking22.
Thus, positive correlations were also expected be-
tween questions Q6 and Q7, which assess coping and 
social consequences, and this result was confirmed. 
Inappropriate strategies are known to contribute to dis-
tortions in social perception and to negative assessment 
of the social consequences7,9.
Similarly, questions Q9 and Q10 showed a high correla-
tion, reinforcing the concept that the perception of difficul-
ties in everyday life is associated with a worse assessment 
of patient well-being/quality of life7,9. Question Q12 sought 
to assess perception of discrimination and showed highly 
significant correlation with questions assessing perceived 
stigma (Q13) and internalized discrimination (Q14). Several 
studies20,21 call attention to the fact that, after a situation is 
evaluated stressful,  the patient usually experiences nega-
tive feelings and dysfunctional behaviors. Souza and Salgado9 
also discuss the psychological process involved.
The three areas also showed highly significant correla-
tions with the total QIRIS score. These results can reinforce 
the evidence of construct validity (when the empirical data 
confirm the theory) and content validity ( fulfilling important 
aspects of the investigated construct)19. The investigation of 
other types of validity evidence, for example, criteria valid-
ity and factor analysis could help researchers to verify the 
instrument dimensionality and add important results to the 
process of instrument construction.
We can see that the instrument enables an interconnec-
tion of the different aspects involved in evaluating the dis-
ease, supporting the concept that cognitive representations 
Table 3. Spearman correlations between QIRIS domains.
 Variable Part1 Part2 Part3
Part2 .16 - -
Part3 .35* .14 -
Total .52** 0.75*** 0.66***
*p ≤ 0.01; **p ≤ 0.001; ***p ≤ 0.0001 
566 Arq Neuropsiquiatr 2016;74(7):561-569
are individual, and controlling the way patients deal with 
the disease also affects adjustment, well-being and the per-
ception of stigma9,10,11.
Another aspect in this study was to combine open-ended 
questions with rating scales, administrated in interview for-
mat. In our study, open questions were important to activate 
relevant ideas and emotions related to epilepsy, according 
to Antonak and Rankin23. Following the model developed by 
Kemp and Morley1, we were the first to develop an interview 
combining open questions and a structured questionnaire to 
assess six representation components of illness.
In our attempt to test if open questions related with oth-
er QIRIS questions, the results were satisfactory, explaining 
more variables and their contents.
Remarkably as well, when we take into account Brazil’s 
socioeconomic reality, the use of perception inventories 
through interviews assists people with low education. 
For that population, it is better to avoid the use of abstract 
terminology, extensive instructions, and wide ranging con-
tents24. Accordingly, the use of both open questions and the 
Likert type of questions enabled the authors to collect more 
reliable data. This is one of the contributions that the instru-
ment aims to bring to the area, as it offers broader and more 
adequate possibilities to evaluate the different population 
strata in terms of educational and social level.
In recent decades, there has been greater interest in the 
study of variables that control the impact of epilepsy, variables 
that go beyond the seizures, remarkably the importance of 
psychosocial conditions and their influence in determining 
the well-being of individuals in chronic medical conditions. 
In contrast to the medical model, the socio-psychological 
model assumes that other personal characteristics affect the 
degree to which patients feel affected in their well-being and 
stigmatized by their condition2,22.
Alongside the development of measures is a need to in-
crease our knowledge of the functional dimensions associ-
ated with neurological disorders.
The result of the assessment depends on information 
brought by the individual patient and his/her symptoms, 
behavioral patterns, perceptions of the disease, and aspects 
of his/her life. This approach encourages clinicians to see pa-
tients as active processors and theorists of their condition, 
and to examine the condition from a patient’s perspective.
This is inherently a psychological approach that has the 
potential to provide greater understanding of what guides 
patients’ behavior3,25. Chronic diseases involve a large num-
ber of behavioral variables, and the scientific question that 
emerges is: how to explain the relationship between behav-
ior and health and behavior and disease, and how to demon-
strate control of this relationship?
We believe that this instrument is a promising tool in 
clinical evaluation and research on adults with epilepsy. The 
results presented in this paper showed that the QIRIS pres-
ents psychometric properties and it is a valid and reliable in-
strument to assess the psychological aspects related with the 
meaning of the disease and the interrelation between quality 
of life and stigma. 
Considering that the research reported here consists of 
the first studies with the instrument, and before the posi-
tive findings, future studies will have to be conducted in 
order to investigate other aspects not covered here. Such 
analysis will allow new evidence of the quality of the pro-
posed instruments, as well as their suitability for its pur-
pose and target population.
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APPeNDIx: QueStIoNNAIRe of ILLNeSS 
RePReSeNtAtIoN, ePILePSy’S ImPACt AND 
StIgmA (QIRIS)
This interview is important to know what you think and 
feel about what you have and we can serve you better.
You will answer some questions that are open and in 
others you must choose one of the scale: 1-Never, 2- Rarely, 
3-Often, 4-Always.
PARt 1 - AttRIbutIoN of meANINg
1. Label. 
1.1 What the name or diagnosis about the 
symptoms that you have?
_______________________________________________
________________________________________________





What do you think caused epilepsy in your case? 
________________________________________________
3. Perception of feelings 
What do you feel when you are in seizures?
3.1 Depression   
1 2 3 4
3.2 Shock   
1 2 3 4
3.3 Fear   
1 2 3 4
3.4 Anxiety   
1 2 3 4
3.5 Sorry for yourself   
1 2 3 4
3.6  Others ______________________
4. Perception of Controllability
Do you think that you have control over your seizure?
1 2 3 4
5. Projecting consequences 
How you imagine your future having seizures? 
________________________________________________
6. Coping
How the people with epilepsy often act?
6.1 Talking to persons about disease.    
1 2 3 4
6.2 Looking for medical treatment. 
1 2 3 4
6.3 Withdrawal   
1 2 3 4
6.4 Act as if they had not epilepsy   
1 2 3 4
6.5 Others ______________________
7. Perception of Social Consequences
What do you guess people think to see someone hav-
ing seizure?
7.1 Fear   
1 2 3 4
7.2 Pity   
1 2 3 4
7.3 They know it’s a seizure   
1 2 3 4
7.4 Help   
1 2 3 4
7.5 They think that it is a contagious disease 
1 2 3 4
7.6 Others ______________________
PARt 2- ImPACt of DISeASe ( QuALIty of LIfe)
8. experience of difficulties 
Can you talk about some difficulties which you have be-
cause of your seizures?
_______________________________________________
________________________________________________
9. Perceptions of difficulties
Which difficulties do you think that people with epilepsy 
have in their daily life?
9.1 Family relationships   
1 2 3 4
9.2 Employment   
1 2 3 4
9.3 School   
1 2 3 4
9.4 Friendship / Dating   
1 2 3 4
9.5 Sexuality   
1 2 3 4
9.6 Emotional   
1 2 3 4
9.7 Prejudice   
1 2 3 4
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9.8 Health   
1 2 3 4
10. Quality of life
What score would you rate your quality of life (satisfaction in 
the aspects mentioned above, as follows: 1 = poor, 10 = great) ?
1 2 3 4 5 6 7 8 9 10
PARt 3 - exPeRIeNCe of StIgmA
11. Can you tell of any situation where people 





In what situation do you think a person with epilepsy is 
discriminated?
12.1 Family relationships   
1 2 3 4
12.2. Friendship   
1 2 3 4
12.3. Employment   
1 2 3 4
12.4. School   
1 2 3 4
12.5. Dating   
1 2 3 4
13. Stigma
What score would you rate for the prejudice that the 
general population has towards epilepsy (1 = no prejudice, 
10 = maximum prejudice)? 
1 2 3 4 5 6 7 8 9 10
14. Perceived Stigma
Do you agree?
14.1 I care when people are afraid of me because of epilepsy
1 2 3 4
14.2 I care when people do not take my opinions as seri-
ously as would take if I had not epilepsy.
1 2 3 4
14.3 I consider myself imperfect because of epilepsy.
1 2 3 4
14.4 People who know I have seizures treat me differently
1 2 3 4
14.5 I have few friends because I have epilepsy
1 2 3 4
14.6 I care what people think of me when they saw me 
having a seizure.
1 2 3 4
